Use of Dexamethasone in Treatment of Insulin Lipoatrophy

Overview

Journal Diabetes

Specialty Endocrinology

Date 1977 Apr 1

PMID 849810

Citations 7

Authors

O Kumar

L Miller

S Mehtalia

Affiliations

Soon will be listed here.

Abstract

To treat insulin lipoatrophy, small amounts of dexamethasone (4 micrograms/unit) were added to insulin injections in nine patients. Six cases showed significant improvement of dexamethasone-treated sites over that of control sites in six months. With the continued use of dexamethasone-containing insulin, they remained mostly free of atrophic areas during the follow-up period of over two years. Our experience suggests the usefulness of this therapy.

Citing Articles

Prevalence, Risk Factors, and Clinical Characteristics of Lipodystrophy in Insulin-Treated Patients with Diabetes: An Old Problem in a New Era of Modern Insulin.

Thewjitcharoen Y, Prasartkaew H, Tongsumrit P, Wongjom S, Boonchoo C, Butadej S Diabetes Metab Syndr Obes. 2020; 13:4609-4620.

PMID: 33273836 PMC: 7705266. DOI: 10.2147/DMSO.S282926.

ISPAD Clinical Practice Consensus Guidelines 2018: Other complications and associated conditions in children and adolescents with type 1 diabetes.

Mahmud F, Elbarbary N, Frohlich-Reiterer E, Holl R, Kordonouri O, Knip M Pediatr Diabetes. 2018; 19 Suppl 27:275-286.

PMID: 30066458 PMC: 6748835. DOI: 10.1111/pedi.12740.

Concurrence of Lipoatrophy and Lipohypertrophy in Children With Type 1 Diabetes Using Recombinant Human Insulin: Two Case Reports.

Singha A, Bhattarcharjee R, Ghosh S, Chakrabarti S, Baidya A, Chowdhury S Clin Diabetes. 2016; 34(1):51-3.

PMID: 26807009 PMC: 4714723. DOI: 10.2337/diaclin.34.1.51.

Relapsing insulin-induced lipoatrophy, cured by prolonged low-dose oral prednisone: a case report.

Chantelau E, Praetor R, Praetor J, Poll L Diabetol Metab Syndr. 2011; 3(1):33.

PMID: 22145998 PMC: 3251526. DOI: 10.1186/1758-5996-3-33.

Insulin-induced lipoatrophy: evidence for an immune pathogenesis.

Reeves W, Allen B, Tattersall R Br Med J. 1980; 280(6230):1500-3.

PMID: 6992934 PMC: 1601688. DOI: 10.1136/bmj.280.6230.1500.